MoneyWorks4Me

Sanofi India - Quaterly Results

26 Jul 2022 Evaluate
The sales declined to Rs. 6993.00 millions for the June 2022 quarter as compared to Rs. 7891.00 millions during the corresponding quarter last year.Net Profit of the company move down -32.47% to Rs. 1204.00  millions from Rs. 1783.00 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 1768.00 millions from 2642.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202112 202012 % Var
Sales 6993.00 7891.00 -11.38 14063.00 15142.00 -7.13 29566.00 29019.00 1.88
Other Income 157.00 171.00 -8.19 401.00 434.00 -7.60 744.00 898.00 -17.15
PBIDT 1768.00 2642.00 -33.08 3957.00 4799.00 -17.55 8369.00 8029.00 4.23
Interest 4.00 5.00 -20.00 8.00 9.00 -11.11 18.00 18.00 0.00
PBDT 1764.00 2637.00 -33.11 5130.00 4790.00 7.10 13243.00 7594.00 74.39
Depreciation 106.00 211.00 -49.76 215.00 415.00 -48.19 667.00 822.00 -18.86
PBT 1658.00 2426.00 -31.66 4915.00 4375.00 12.34 12576.00 6772.00 85.71
TAX 454.00 643.00 -29.39 1327.00 1133.00 17.12 3132.00 1996.00 56.91
Deferred Tax -10.00 -33.00 -69.70 32.00 -83.00 -138.55 -228.00 -114.00 100.00
PAT 1204.00 1783.00 -32.47 3588.00 3242.00 10.67 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 25.28 33.48 -24.49 28.14 31.69 -11.22 28.31 27.67 2.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..